An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China

NCT05728502 · clinicaltrials.gov ↗

COMPLETED

Status

2400

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Vericiguat (Verquvo, BAY1021189)
DRUG: Standard of Care (SoC)

Sponsor

Bayer